Illumina Launches SpliceAI2 Model for Splice Variant Interpretation

Illumina introduced SpliceAI2 on October 8, 2026, a genomic AI model from its BioInsight AI Lab that predicts how genetic variants alter RNA splicing. Illumina said the model identified 17% more disease-relevant variants than other splicing models when applied to a rare disease research dataset. According to the company's announcement, SpliceAI2 is designed to help researchers identify disease-relevant splice variants that might otherwise go unnoticed, with splice effect prediction key to…

Read the original article: